Postpartum Posterior Reversible Encephalopathy Syndrome in a Patient Suspected to COVID-19

Author(s): Fatemeh Ramezanpour, Ashraf Zarvani, Athena Sharifi-Razavi*

Journal Name: Anti-Infective Agents
Formerly Anti-Infective Agents in Medicinal Chemistry

Volume 19 , Issue 3 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

The effect of a novel beta coronavirus named SARS-CoV-2 or COVID-19 on pregnancy outcomes and the neonatal prognosis is not fully documented yet.

Case Presentation: In this article, we describe a patient presented with frequent seizure and blurred vision 6 days after delivery without symptoms and laboratory data in favor of preeclampsia/eclampsia and evaluations consistent with Posterior Reversible Encephalopathy Syndrome. Also, there was mild clinical and radiological evidence of COVID-19 infection.

Conclusion: In conclusion, as pregnancy is a high-risk state, pregnant women may be more vulnerable to severe COVID-19 infection and also pregnancy complications.

Keywords: Betacoronavirus, radiological evidence, COVID-19 infection, encephalopathy, maternal-fetal transmission, levetiracetam.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 3
Year: 2021
Published on: 03 June, 2021
Page: [341 - 344]
Pages: 4
DOI: 10.2174/2211352518999201117093045
Price: $25

Article Metrics

PDF: 8